Page 53 - 2023-08-中国全科医学

·950· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn March 2023, Vol.26 No.8

10.1038/s41467-019-09234-6. ［25］AHMADIEH S，KIM H W，WEINTRAUB N L. Potential role of
［11］SHANNON P，MARKIEL A，OZIER O，et al. Cytoscape： perivascular adipose tissue in modulating atherosclerosis［J］.
a software environment for integrated models of biomolecular Clin Sci （Lond），2020，134（1）：3-13. DOI：
interaction networks［J］. Genome Res，2003，13（11）： 10.1042/CS20190577.
2498-2504. DOI：10.1101/gr.1239303. ［26］LIU Y，SUN Y，LIN X Z，et al. Perivascular adipose-derived
［12］OIKONOMOU E K，WILLIAMS M C，KOTANIDIS C P，et al. exosomes reduce macrophage foam cell formation through miR-
A novel machine learning-derived radiotranscriptomic signature of 382-5p and the BMP4-PPARγ-ABCA1/ABCG1 pathways［J］.
perivascular fat improves cardiac risk prediction using coronary CT Vascul Pharmacol，2022，143：106968. DOI：10.1016/j.
angiography［J］. Eur Heart J，2019，40（43）：3529-3543. vph.2022.106968.
DOI：10.1093/eurheartj/ehz592. ［27］LI X Z，BALLANTYNE L L，YU Y，et al. Perivascular adipose
［13］SATO T，AIZAWA Y，YUASA S，et al. The effect of dapagliflozin tissue-derived extracellular vesicle miR-221-3p mediates vascular
treatment on epicardial adipose tissue volume［J］. Cardiovasc remodeling［J］. FASEB J，2019，33（11）：12704-12722.
Diabetol，2018，17（1）：6. DOI：10.1186/s12933-017-0658-8. DOI：10.1096/fj.201901548R.
［14］SAGE A P，MURPHY D，MAFFIA P，et al. MHC Class II- ［28］MARKOVICD，JEVTOVIC-STOIMENOV T，COSIC V，et al.
restricted antigen presentation by plasmacytoid dendritic cells drives Clinical utility of survivin （BIRC5），novel cardiac biomarker，as
proatherogenic T cell immunity［J］. Circulation，2014，130（16）： a prognostic tool compared to high-sensitivity C-reactive protein，
1363-1373. DOI：10.1161/CIRCULATIONAHA.114.011090.
heart-type fatty acid binding protein and revised lee score in elderly
［15］FAN Z W，LI J F，LI P，et al. Protein arginine methyltransferase
patients scheduled for major non-cardiac surgery：a prospective
1 （PRMT1）represses MHC Ⅱ transcription in macrophages
pilot study［J］. J Med Biochem，2018，37（2）：110-120.
by methylating CIITA［J］. Sci Rep，2017，7：40531. DOI：
DOI：10.1515/jomb-2017-0046.
10.1038/srep40531.
［29］BEDENBENDER K，SCHMECK B T. Endothelial ribonuclease 1
［16］WU X Y，KONG X C，CHEN D W，et al. SIRT1 links CIITA
in cardiovascular and systemic inflammation［J］. Front Cell Dev
deacetylation to MHC Ⅱ activation［J］. Nucleic Acids Res，
Biol，2020，8：576491. DOI：10.3389/fcell.2020.576491.
2011，39（22）：9549-9558. DOI：10.1093/nar/gkr651.
［30］T AVAKOL IAN F ERDOUSIE V，MOHAMMADI M，
［17］KONG X C，FANG M M，LI P，et al. HDAC2 deacetylates class
HASSANSHAHI G，et al. Serum CXCL10 and CXCL12 chemokine
Ⅱ transactivator and suppresses its activity in macrophages and
levels are associated with the severity of coronary artery disease and
smooth muscle cells［J］. J Mol Cell Cardiol，2009，46（3）：
coronary artery occlusion［J］. Int J Cardiol，2017，233：23-28.
292-299. DOI：10.1016/j.yjmcc.2008.10.023.
DOI：10.1016/j.ijcard.2017.02.011.
［18］IBORRA S，GONZÁLEZ-GRANADO J M. In vitro differentiation
+
of naïve CD 4 T cells：a tool for understanding the development of ［31］MAUSE S F，RITZEL E，DECK A，et al. Engagement of the
CXCL12-CXCR4 axis in the interaction of endothelial progenitor
atherosclerosis［J］. Methods Mol Biol，2015，1339：177-189.
cell and smooth muscle cell to promote phenotype control and guard
DOI：10.1007/978-1-4939-2929-0_12.
vascular homeostasis［J］. Int J Mol Sci，2022，23（2）：867.
［19］GADDIS D E，PADGETT L E，WU R P，et al. Atherosclerosis
+
impairs naive CD 4 T-cell responses via disruption of DOI：10.3390/ijms23020867.
［32］SNARSKI P，SUKHANOV S，YOSHIDA T，et al. Macrophage-
glycolysis［J］. Arterioscler Thromb Vasc Biol，2021，41（9）：
specific IGF-1 overexpression reduces CXCL12 chemokine levels
2387-2398. DOI：10.1161/ATVBAHA.120.314189.
and suppresses atherosclerotic burden in apoe-deficient mice［J］.
［20］XIA X D，WANG M M，LI J，et al. Identification of potential genes
associated with immune cell infiltration in atherosclerosis［J］. Arterioscler Thromb Vasc Biol，2022，42（2）：113-126. DOI：
Math Biosci Eng，2021，18（3）：2230-2242. DOI： 10.1161/ATVBAHA.121.316090.
10.3934/mbe.2021112. ［33］LI F C，YAN K M，WU L L，et al. Single-cell RNA-seq reveals
［21］HUANG J，ZHOU Q. Identification of the relationship between cellular heterogeneity of mouse carotid artery under disturbed
hub genes and immune cell infiltration in vascular endothelial flow［J］. Cell Death Discov，2021，7（1）：180. DOI：
cells of proliferative diabetic retinopathy using bioinformatics 10.1038/s41420-021-00567-0.
methods［J］. Dis Markers，2022，2022：7231046. DOI： ［34］HUBACEK J A，PITHA J，SKODOVÁ Z，et al. Polymorphisms
10.1155/2022/7231046. in the lipopolysaccharide-binding protein and bactericidal/
［22］LI Y N，GUO X J，XUE G H，et al. RNA Splicing of permeability-increasing protein in patients with myocardial
the Abi1 Gene by MBNL1 contributes to macrophage-like infarction［J］. Clin Chem Lab Med，2002，40（11）：1097-
phenotype modulation of vascular smooth muscle cell during 1100. DOI：10.1515/CCLM.2002.191.
atherogenesis［J］. Cell Prolif，2021，54（5）：e13023. DOI： ［35］BLEIJERVELD O B，WIJTEN P，CAPPADONA S，et al. Deep
10.1111/cpr.13023. proteome profiling of circulating granulocytes reveals bactericidal/
［23］CHEN A Q，GAO X F，WANG Z M，et al. Therapeutic permeability-increasing protein as a biomarker for severe
exosomes in prognosis and developments of coronary artery atherosclerotic coronary stenosis［J］. J Proteome Res，2012，
disease［J］. Front Cardiovasc Med，2021，8：691548. DOI： 11（11）：5235-5244. DOI：10.1021/pr3004375.
10.3389/fcvm.2021.691548. ［36］COLE J W. F2R polymorphisms and clopidogrel efficacy and safety：
［24］BOND S T，CALKIN A C，DREW B G. Adipose-derived another step toward precision medicine［J］. Neurology，2021，96
extracellular vesicles：systemic messengers and metabolic regulators （1）：10-11. DOI：10.1212/WNL.0000000000011085.
in health and disease［J］. Front Physiol，2022，13：837001. （收稿日期：2022-07-06；修回日期：2022-08-28）
DOI：10.3389/fphys.2022.837001. （本文编辑：徐真）